Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1981 1
1982 1
1987 3
1989 2
1991 4
1992 2
1993 2
1994 5
1995 3
1996 4
1997 3
1998 2
1999 6
2000 4
2001 1
2002 2
2003 2
2004 3
2005 4
2006 2
2008 5
2009 5
2010 9
2011 11
2012 8
2013 10
2014 9
2015 5
2016 5
2017 10
2018 8
2019 6
2020 6
2021 15
2022 5
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.
Pernigoni N, Zagato E, Calcinotto A, Troiani M, Mestre RP, Calì B, Attanasio G, Troisi J, Minini M, Mosole S, Revandkar A, Pasquini E, Elia AR, Bossi D, Rinaldi A, Rescigno P, Flohr P, Hunt J, Neeb A, Buroni L, Guo C, Welti J, Ferrari M, Grioni M, Gauthier J, Gharaibeh RZ, Palmisano A, Lucchini GM, D'Antonio E, Merler S, Bolis M, Grassi F, Esposito A, Bellone M, Briganti A, Rescigno M, Theurillat JP, Jobin C, Gillessen S, de Bono J, Alimonti A. Pernigoni N, et al. Among authors: bellone m. Science. 2021 Oct 8;374(6564):216-224. doi: 10.1126/science.abf8403. Epub 2021 Oct 7. Science. 2021. PMID: 34618582
Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E, Di Martile M, Brignone M, Di Caprio M, Manni I, Chiappa M, Sergio I, Chiacchiarini M, Bazzichetto C, Conciatori F, D'Aguanno S, D'Angelo C, Ragno R, Russillo M, Colotti G, Marchesi F, Bellone ML, Dal Piaz F, Felli MP, Damia G, Del Bufalo D. Valentini E, et al. Among authors: bellone ml. Cell Death Dis. 2023 Jul 17;14(7):441. doi: 10.1038/s41419-023-05963-1. Cell Death Dis. 2023. PMID: 37460459 Free PMC article.
Immunosuppression via Tenascin-C.
Bellone M, Caputo S, Jachetti E. Bellone M, et al. Oncoscience. 2015 Aug 21;2(8):667-8. doi: 10.18632/oncoscience.210. eCollection 2015. Oncoscience. 2015. PMID: 26425650 Free PMC article. No abstract available.
Cancer immunity and immunotherapy beyond COVID-19.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Bellone M, et al. Cancer Immunol Immunother. 2023 Jul;72(7):2541-2548. doi: 10.1007/s00262-023-03411-9. Epub 2023 Mar 30. Cancer Immunol Immunother. 2023. PMID: 36995489 Free PMC article. No abstract available.
Long non-coding RNAs as novel therapeutic targets in cancer.
Lavorgna G, Vago R, Sarmini M, Montorsi F, Salonia A, Bellone M. Lavorgna G, et al. Among authors: bellone m. Pharmacol Res. 2016 Aug;110:131-138. doi: 10.1016/j.phrs.2016.05.018. Epub 2016 May 19. Pharmacol Res. 2016. PMID: 27210721 Review.
177 results